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Table 1
Kontrol Distal VTE
Proksimal
VTE PTE P value
NLR 1.800.70 2.731.34 3.221.26 4.101.40 <0.001
WBC 6.50.95 6.61.76 8.22.26 10.12.8 <0.001
Hs-CRP 0.680.35 0.650.35 1.541.33 3.483.95 <0.001
The distribution of NLR, WBC and hs-CRP values between the control group and the sub-
groups of VTE. Abbreviations: NLR, neutrophil to lymphocyte ratio; WBC, white blood cell; hs-
CRP, high-sensitivity C-reactive protein.
Table 1. Baseline characteristics and laboratory ﬁndings of the study groups
Variables
Control group
(n=46)
Risky group
(n=36) P value
Age (years) 13.911.31 14.561.73 0.060
Gender (Male) 26 (57) 20 (56) 0.930
Body mass index
(kg/m2)
19.783.25 20.293.59 0.500
Systolic blood
pressure (mmHg)
111.8512.75 113.3114.73 0.633
Diastolic blood
pressure (mmHg)
69.468.11 72.449.10 0.121
Total cholesterol
(mg/dl)
156.7627.62 165.1235.60 0.403
Triglyceride (mg/dl) 112.3555.16 104.9148.44 0.626
LDL-C (mg/dl) 84.2322.26 93.7632.30 0.282
HDL-C (mg/dl) 63.6513.41 56.5514.95 0.106
Creatinine (mg/dl) 0.490.11 0.510.13 0.644
Fasting glucose
(mg/dl)
87.639.91 90.279.19 0.275
Hemoglobin (g/dl) 12.350.85 12.311.25 0.899
hs-CRP (mg/L) 0.46 [0.24-1.62] 0.36 [0.23-0.75] 0.582
LDL-C low-density lipoprotein cholesterol; HDL high-density lipoprotein cholesterol; hs-CRP
high sensitivity C-reactive protein. Data are shown as n (%), meanSD, median [IQR].
Table 2. Distribution of genotype and allele frequencies and odds ratios and
95% conﬁdential intervals of the atherosclerosis risk among CRP, eNOS, and
IL-6 polymorphisms
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CRP +1444 C/T
Genotypes 0.585
C/C 24 (52.2) 16 (44.4)
C/T 19 (41.3) 19 (52.8)
T/T 3 (6.5) 1 (2.8)
Alleles 0.390 1.10 (0.56-2.18)
C 67 (72.8) 51 (70.8)
T 25 (27.2) 21 (29.2)
eNOS -786 T/C
Genotypes 0.502
T/T 28 (60.9) 18 (50.0)
T/C 11 (23.9) 13 (36.1)
C/C 7 (15.2) 5 (13.9)
Alleles 0.255 1.26 (0.64-2.46)
T 67 (72.8) 49 (68.1)
C 25 (27.2) 23 (31.9)
IL-6 -572 G/C
Genotypes 0.012
G/G 42 (91.3) 25 (69.4)
G/C 3 (6.5) 10 (27.8)
C/C 1 (2.2) 1 (2.8)
Alleles 0.012 3.48 (1.17-10.32)
G 87 (94.5) 60 (83.3)
C 5 (5.4) 12 (16.6)
CRP C-reactive protein, NOS nitric oxide synthase, IL-6 interleukin-6. Data are shown as n (%).
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Objectıve: The aim of this study was to investigate the relationship between the
anatomic extent of venous thromboembolism (VTE) and nonspeciﬁc inﬂammatoryC126 JACC Vomarkers such as Neutrophil to lymphocyte ratio (NLR) and high-sensitivity C-reactive
protein (hs-CRP).
Methods: We retrospectively enrolled 77 patients with VTE (Distal deep vein
thrombosis (DVT) (n¼19), proximal DVT (n¼32) and pulmonary thomboembolism
(PTE) (n¼26)) and 34 healthy controls. Distal and proximal DVT was diagnosed by
using peripheral vascular duplex ultrasonography. Proximal DVT was deﬁned as
thrombosis at the level of the popliteal veins or above. Distal DVT was deﬁned as
thrombosis occurring within the calf veins. The diagnosis of PTE was conﬁrmed in all
cases by computed tomography. Total and differential leukocyte count and hs-CRP
were determined by standard laboratory.
Results: It was detected in patients with VTE that WBC (8.50.26 vs 6.50.95,
p<0.001), NLR (3.411.41 vs 1.800.70, p<0.001) and hs-CRP(2.002.68 mg/L vs
0.680.35 mg/L, p¼0.005) levels were signiﬁcantly higher in comparison with the
healthy control group. According to the analysis made by ANOVA, the levels of
WBC, NLR and hs-CRP were clearly different among the groups (control, distal and
proximal DVT and PTE) (p<0.001). According to ANOVA test with LSD as a post-
hoc test performed to ﬁnd the source of the difference between the groups, only hs-
CRP was found high in PTE group in comparison with the other groups; and no
difference was detected between the other groups. A signiﬁcant increase from the
control group to DVT and PTE was observed in the analysis made for NLR. In the
analysis for WBC, while there was no difference between the control group and distal
DVT, it was found signiﬁcantly higher in the proximal DVT and PTE (Table 1). ROC
curve analysis was performed in order to ﬁnd the best cut-off values of these variables
in predicting VTE. AUC:0.849, p<0.001 was detected for NLR>1.84. For this value,
sensitivity as 88.2% and speciﬁty as 67.6% was determined. AUC:0.741, p<0.001
was detected for Hs-CRP>1.17. For this value, sensitivity as 45.6% and speciﬁty as
94.1% was determined. For WBC>7.7, AUC:0.761, p<0.001 was detected. For this
value, sensitivity as 57.4% and speciﬁty as 91.2% was determined. ROC curve-AUC
values of each three variables were compared. While there was no signiﬁcant
difference between hs-CRP and WBC (p¼0.742), it was observed that there was
a clear difference between both NLR and WBC (p¼0.078), and NLR and hs-CRP
(p¼0.044) (Figure 1).
Conclusıons: These ﬁndings suggest that the inﬂammatory process might have an
important role in the prothrombotic state in patients with VTE. Also, NLR may be
effective in determining the anatomic extent of VTE. NLR is inexpensive and
readily available markers that may be useful for risk stratiﬁcation in patients with
VTE.PP-113
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